Crystalline (2s)-3-[(3s,4s)-3-[(1r)-1-hydroxyethyl]-4-(4-methoxy-3-{ [1-(5-methylpyridin-2-yl)azetidin-3-yl]oxy} phenyl) -3-methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol
- 专利权人:
- ELI LILLY AND COMPANY
- 发明人:
- Huang, Ping,Ribe, Seth Dietrich
- 申请号：
- NZ72835915
- 公开号：
- NZ728359A
- 申请日:
- 2015.08.28
- 申请国别(地区):
- NZ
- 年份:
- 2018
- 代理人:
- 摘要：
- The invention provides crystalline (2S)-3-[(3S,4S)-3-[(1R)-1-hydroxyethyl]-4-(4-methoxy-3-{ [1-(5-methylpyridin-2-yl)azetidin-3-yl]oxy} phenyl)-3-methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol, and pharmaceutical compositions thereof. The invention further provides methods of using this compound to treat overactive bladder.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- 2S-3-[3S4S-3-[1R-1-]-4-4--3-[1-5--2--3-]-3--1-]-3--12- CRYSTALLINE 2S-3-[3S4S-3-[1R-1-HYDROXYETHYL]-4-4-METHOXY-3-[1-5-METHYLPYRIDIN-2-YLAZETIDIN-3-YL]OXYPHENYL-3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-12-DIOL
- Crystalline (2S)-3-[(3S,4S)-3-[(1R)-1- hydroxyethyl]-4-(4-methoxy-3-{[1-(5- methylpyridin-2-yl)azetidin-3-yl]oxy}phenyl)-3- methylpyrrolidin-1-yl]-3-oxopropane-1,2-diol
- CRYSTALLINE (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL) -3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-1,2-DIOL
- CRYSTALLINE (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL) -3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-1,2-DIOL
- CRYSTALLINE (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL) -3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-1,2-DIOL
